>> HOMEPAGE

Aids Research

Clinical correlates of subnormal vitamin B12 levels in patients infected with the human immunodeficiency virus.

American journal of hematology; VOL: 49 (4); p. 318-22

Paltiel O; Falutz J; Veilleux M; Rosenblatt DS; Gordon K

OBJECTIVES: To determine the prevalence and describe the clinical correlates of subnormal cobalamin levels in subjects infected with the human immunodeficiency virus (HIV), and to assess its relationship to virus-mediated immunosuppression and/or anti-viral therapy. SETTING: Outpatient referral clinic in tertiary care hospital. PATIENT POPULATION: 200 HIV infected individuals. STUDY DESIGN: Descriptive cross sectional survey, with prospective follow-up in a subgroup of patients before and after initiation of zidovudine therapy. MEASURES: Routine complete blood count, serum B12 assay, CD4 counts. Serum homocysteine levels, and Schilling tests were performed on subgroups of study subjects. RESULTS: Subnormal serum B12 levels were found in 61 subjects (30.5%). B12 deficient subjects were more likely to be taking zidovudine. (P = .007). Serum homocysteine levels were significantly higher in patients with subnormal cobalamin levels but were unrelated to CD4 counts or zidovudine use, and were rarely outside of the normal range. Malabsorption of vitamin B12 as evidenced by abnormal Schilling tests was more likely among patients with more advanced HIV disease, or gastrointestinal symptoms but was not necessarily associated with low B12 levels. CONCLUSIONS: Decreased cobalamin levels are found frequently in HIV disease, especially among those treated with zidovudine. Evidence of B12 malabsorption is found among those with more advanced disease and gastrointestinal symptoms.

Sitemap

Was ist neu:

Unsere Verantwortung für die Schaffung einer Welt der Gesundheit, des Friedens und der sozialen Gerechtigkeit

Neue Studie würdigt die Rolle von Vitamin C bei der Reduktion von herzkreislaufbedingter Sterblichkeit

Mehr Kranke bitte! – Abrechnungsbetrügerei mit System

Wenn Arzneimittel verpflichtend werden: Pharma stiftet Gerichte dazu an, Opiod-Abhängige einem Drogenprogramm zu unterwerfen – mit Kosten von $1000 je Injektion

Depressionen infolge Vitamin B-Mangel – ein neuer wissenschaftlicher Review steigert die Beweislast

Neue Metaanalyse stellt wiederum den Nutzen von Magnesium bei Bluthochdruck unter Beweis

Die Cholesterin-Herzinfarkt-Hypothese ist “tot”, bestätigt die britische Königliche Pharmazeutische Gesellschaft

Erfrischung pur – Über die Bedeutung von Trinkwasser im menschlichen Körper

» Natürliche Gesundheit

» "Geschäft m. d. Krankheit"

» Internationale Kampagne

» Dr. Raths Offene Briefe

» Studien weltweit

» Studien auf Deutsch

» Helfen Sie mit!

» Codex Alimentarius

» Dossiers

» Sitemap

Dr. Rath Health Foundation auf Facebook Dr. Rath Health Foundation auf YouTube Dr. Rath Health Foundation auf Twitter RSS
 © 2017 Dr. Rath Health Foundation | Kontakt | Impressum | RSS Feed